Slideshow

Neurological Disorders and the Global Burden of Disease

Author(s):

Veronica Hackethal, MD

Migraine is the second leading cause of disability worldwide. New data show the number of patients who will need care by clinicians with expertise in neurological conditions will continue to grow in coming decades.

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!
Related Videos
Related Content
Merz’ IncobotulinumtoxinA Begins Phase 3 MINT Trials for Migraine Prevention
August 28th 2025

Merz’ IncobotulinumtoxinA Begins Phase 3 MINT Trials for Migraine Prevention

Marco Meglio
Special Episode: Breaking Down the FDA’s Latest Migraine Therapy Approvals with Stewart Tepper, MD
August 28th 2025

Special Episode: Breaking Down the FDA’s Latest Migraine Therapy Approvals with Stewart Tepper, MD

Marco Meglio Stewart Tepper, MD
NeuroVoices: Patricia Pozo-Rosich, MD, PhD, on Fremanezumab's Expanded Indication in Pediatrics
August 28th 2025

NeuroVoices: Patricia Pozo-Rosich, MD, PhD, on Fremanezumab's Expanded Indication in Pediatrics

Marco Meglio
Sleeping Around the Podcast × NeurologyLive: Erenumab, Migraine, and Sleep
August 28th 2025

Sleeping Around the Podcast × NeurologyLive: Erenumab, Migraine, and Sleep

Anne Marie Morse, DO, FAASM NeurologyLive® Staff
Electronic Health Record Study Finds No Significant Cardiovascular Risk With Triptan Use for Migraine
August 28th 2025

Electronic Health Record Study Finds No Significant Cardiovascular Risk With Triptan Use for Migraine

Marco Meglio
Openwater’s LIFU Technology at MIT: A New Era for Consciousness and Neurological Care
August 28th 2025

Openwater’s LIFU Technology at MIT: A New Era for Consciousness and Neurological Care

Marco Meglio
© 2025 MJH Life Sciences

All rights reserved.